Intuitive Surgical, Inc. vs Norwegian Cruise Line Holdings Ltd — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Norwegian Cruise Line Holdings Ltd trades at $15.57 (market cap $7.11B). The key difference: Intuitive Surgical, Inc. is far larger — about 20.6× Norwegian Cruise Line Holdings Ltd's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Norwegian Cruise Line Holdings Ltd for 68 Days on average.
| ISRG | NCLH | |
|---|---|---|
Market Cap | $146.76B | $7.11B |
Volume | 2,529,814 | 22,683,268 |
Sector | Health | Consumer Cyclical |
52-Week High | $592.85 | $25.02 |
52-Week Low | $332.02 | $14.12 |
Typical Hold Time | 84 Days | 68 Days |
Enterprise Value | $141.54B | $21.93B |
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
Norwegian Cruise Line Holdings (NCLH) trades at $15.49, up 2.92% on the day, with a bullish technical signal and recent earnings beats driving momentum. The company shows strong profitability with a 7.49% net income margin and attractive valuation metrics, including a P/E of 9.39. Recent news highlights management's focus on booking strategies and debt management, with a $950 million senior notes offering priced in September 2026. Analyst consensus is positive, with a $20.86 price target implying significant upside from current levels.
The outlook for NCLH is cautiously optimistic, supported by earnings strength and analyst buy ratings, but risks include high debt levels and yield pressure. Investment opportunity lies in valuation discount and operational improvements, though investors must monitor competitive dynamics and macroeconomic sensitivity. The stock's trajectory hinges on sustained demand and effective capital allocation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →